CYTX Cytori Therapeutics Inc.

0.27
+0.04  (+16%)
Previous Close 0.23
Open 0.24
Price To Book 1.59
Market Cap 5,982,065
Shares 22,155,795
Volume 4,289,414
Short Ratio
Av. Daily Volume 647,841

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Pivotal trial data released June 24, 2017 - endpoints not met.
ECCS-50
Scleroderma
Phase 2 planned.
ATI-1123
Platinum-sensitive small cell lung cancer